Skip to main content

AMGN STOCK WRITE UP


AMGN

  • P/E: 16.1
  • GAAP EPS Y-O-Y GROWTH LAST QUARTER: $.22
  • SECTOR: HEALTH TECHNOLOGY
  • ASSETS-LIABILITIES: 1.62
  • DIVIDEND: 2.54%

Amgen is a leading biotech company with a solid financial foundation. It has managed to reduce its spending on research and development while increasing revenue through its sales of established drugs such as Enbrel, and Prolia. The company has several rapidly growing drugs that are newer to the market, with many drugs in the company's pipeline.
In its last quarter, Amgen posted 7.7% revenue growth with 7.5% net income growth. The company spent less, however, in the most recent quarter when compared with the comparable quarter from the prior year, on research and development. The reduction in operating margin came from an increased interest expense in the quarter. Although the company spent less on research and development, its revenue did increase. Amgen is continuing to innovate despite reduced research and development budget, with several drugs in late stage trials. The company will be able to sustain growth if its upcoming drugs are successful.
Robert A Bradway, the company's CEO, previously worked as an investment banker in Morgan Stanley's healthcare division. Although Amgen lost $150 million of its revenue on its largest drug, Enbrel, Marketwatch reports that the company narrative and pipeline are positive. Positive news surrounding the company's Repatha, Prolia, and Xgeva drugs could be promising for the company, according to Marketwatch. Wall Street has predicted the company will report earnings of $3 in the quarter reporting 4/26/2017.
The company has a solid financial foundation. Its price-to-earnings multiple is relatively low, giving the share price opportunity to increase to reveal the company's true value. Additionally, a large yield provides investors of AMGN with guaranteed investment return at 2.54%. Amgen has a good ratio of assets to liabilities, and is reducing its operation costs while its revenue is increasing. While Amgen is not the largest company in its sector, it has solid growth and strong financial backing.

SOURCES:






Labels:

Comments

Post a Comment

Popular posts from this blog

FL STOCK WRITE UP

FL (FOOT LOCKER) P/E: 15.2 GAAP DILUTED YO-Y EPS GROWTH LAST QUARTER: $.28 SECTOR: RETAIL TRADE ASSETS-LIABILITIES: 3.39 DIVIDEND: 1.68% According to statisticbrain, Foot Locker was the largest shoe retailer in the United States as of 8/13/2016. Foot Locker posted a 24.5% year-over-year EPS gain in the most recent quarter, meaning its successful business is still growing. The company has a low price-to-earnings multiple and a high rate of growth with solid financials, giving the stock room to climb. While many retail stores have faired poorly due to the recent emergence of Amazon and other online retailers, Foot Locker does not suffer because their services are hard to duplicate online. You can not try on a shoe from Amazon prior to purchasing, for example. For customers who do not need to try on the shoe, either because they have already purchased the same shoe, or have tried on shoes of the same brand, Foot Locker also sells shoes through Amazon. In th...
Post a Comment
Read more

GOOG STOCK WRITE UP

GOOG (ALPHABET INC) P/E: 31.7 GAAP DILUTED EPS GROWTH Q4 '15 to Q4 '16: $.50 SECTOR: TECHNOLOGY SERVICES ASSETS-LIABILITIES: 5.8 DIVIDEND: NONE This stock is a new addition to my portfolio. The price-to-earnings multiple is higher than my target price-to-earnings multiple, but I decided to purchase the stock due to its solid year-over-year EPS growth, positive chart alignment, positive cash flow, ubiquitous market presence, and rapid growth in the technology sector. I believe this stock will head much higher, and that its earnings will keep up with the rapid pace of its growth to ensure its stability. Google became a popular product due to its excellent search engine. As a result of its success, with approximately 80.5% of global market share according to a recent survey, Google has built a strong revenue base through its advertising services. However, Google has taken the challenge of expanding its services beyond the search engine field i...
Post a Comment
Read more

TTC STOCK WRITE UP

TTC (THE TORO COMPANY) P/E: 31.6 GAAP DILUTED YEAR-OVER-YEAR EPS GROWTH LAST QUARTER: $.06 SECTOR: PRODUCER MANUFACTURING ASSETS-LIABILITIES: 2.8 DIVIDEND: 1.05% TTC is the symbol for Toro, a manufacturer of lawnmowers, irrigation and lighting systems, and other tools for residential and professional landscaping. They utilize high-quality products and deliver them in a reliable package to their customers. Toro reports 5/25/17, and will attempt to demonstrate business growth in line with expectations. In the most recent quarter, Toro reported a 6% boost in revenue and an increase in operating costs by just under 6%. The company utilized some of its 35% increase in cash to repurchase stock. Inventories and receivables were cut on a year-over-year basis, signifying that the company is fulfilling orders more rapidly. Professional services make up the bulk of the company's revenue at approximately 80%. While residential revenue decreased on a year-over...
Post a Comment
Read more